MASSDEVICE ON CALL — Medical device giant Edwards Lifesciences (NYSE:EW) has a rosy outlook for the future, including an anticipated doubling of its Utah workforce from about 500 to 1,000 employees.
The new jobs span a variety of positions at the company’s facility in Draper, Utah, including administrating, engineering and manufacturing roles, a spokeswoman told a local paper.
"Edwards Lifesciences has experienced tremendous growth over the last few years," Edwards global communications senior manager Janet Kim told the Draper Journal.
That growth was driven most recently by Edwards’ November 2011 FDA win for its Sapien transcatheter aortic valve implantation system, which remains the only such device approved for the U.S. market, Kim told reporters.
Congress approves another "doc fix"
Lawmakers approve a new "doc fix" in the latest fiscal cliff negotiations, putting off for another year a final resolution to the impending Medicare reimbursements cuts.
Read more
Electrical opiates stimulate the brain
Researchers were able to simulate the function of one of the body’s most powerful painkillers by stimulating specific regions of the brain with electrical pulses.
Read more
Watching chemo kill tumors in real time
CT scanning allows researchers to watch chemotherapy destroy cancerous tumors in the liver in real time, allowing healthcare providers to determine whether a given path of treatment was effective.
Read more
Preschool obesity on the decline?
Researchers analyzed data from the Pediatric Nutrition Surveillance System, concluding that rates of obesity among preschool-aged children may be on the decline.
Read more
